因持续肥胖行修正性减重手术患者的特征与结局:10,589例回顾性队列研究
基于2020年MBSAQIP登记数据,比较初次择期与因减重不足行修正性减重手术的患者特征及安全性结局。共纳入158,424例,修正性手术10,589例(6.7%)。修正性手术患者女性更多、BMI更低、代谢合并症更少,但30天再入院和再手术率更高,且独立关联严重并发症增加,30天死亡率无显著差异。
要点
- 修正性减重手术占全部减重手术的6.7%,最常见术式为Roux-en-Y胃旁路术(48.4%)和袖状胃切除术(32.5%)。
- 修正性手术患者30天再入院率4.8%、再手术率2.4%,均显著高于初次手术(2.9%、1.0%)。
核心结论
- 与初次减重手术相比,修正性手术患者代谢合并症更少,但围术期结局更差且独立关联严重并发症。
研究设计与样本
- 回顾性队列研究,分析2020年MBSAQIP登记数据,比较初次择期与因减重不足行修正性减重手术,共158,424例,其中修正性10,589例(6.7%)。
主要发现
- 修正性手术患者女性比例更高(85.5% vs 81.0%,P<0.001),BMI更低(43.6±7.8 kg/m2 vs 45.2±7.8 kg/m2,P<0.001),代谢合并症更少。
- 修正性手术最常见术式为Roux-en-Y胃旁路术(48.4%)和袖状胃切除术(32.5%),手术时间更长。
- 修正性手术30天再入院率4.8% vs 2.9%(P<0.001),再手术率2.4% vs 1.0%(P<0.001)。
临床怎么用
- 修正性减重手术患者围术期风险更高,应加强术后30天内监测与随访,重点关注再入院和再手术风险。
- 修正性手术不增加30天死亡风险,但严重并发症风险独立升高,术前决策需权衡获益与风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Revisional bariatric surgery in an option for patients who experience weight regain or inadequate weight loss after primary elective bariatric procedures. However, there is conflicting data on safety outcomes of revisional procedures. We aim to characterize patient demographics, procedure type, and safety outcomes for those undergoing revisional compared to initial bariatric interventions to guide management of these patients. METHODS: The 2020 Metabolic and Bariatric Accreditation and Quality Improvement Program (MBSAQIP) registry was analyzed, comparing primary elective to revisional bariatric procedures for inadequate weight loss. Bivariate analysis was performed to determine between group differences. Multivariable logistic regression determined factors associated with serious complications or mortality. RESULTS: We evaluated 158,424 patients, including 10,589 (6.7%) revisional procedures. Patients undergoing revisional procedures were more like to be female (85.5% revisional vs. 81.0% initial; p < 0.001), had lower body mass index (43.6 ± 7.8 kg/m2 revisional vs. 45.2 ± 7.8 kg/m2 initial; p < 0.001), and less metabolic comorbidities than patients undergoing primary bariatric surgery. The most common revisional procedures were Roux-en-Y gastric bypass (48.4%) and sleeve gastrectomy (32.5%). Revisional procedures had longer operative duration compared to primary procedures. Patients undergoing revisional procedures were more likely to experience readmission to hospital (4.8% revisional vs. 2.9% initial; p < 0.001) and require reoperation (2.4% revisional vs. 1.0% initial; p < 0.001) within 30 days of the procedure. Revisional procedures were independently associated with increased serious complications (OR 1.49, CI 1.36-1.64, p < 0.001) but were not a significant predictor of 30-day mortality (OR 0.74, CI 0.36-1.50, p = 0.409). CONCLUSIONS: In comparison to primary bariatric surgery, patients undergoing revisional procedures have less metabolic comorbidities. Revisional procedures have worse perioperative outcomes and are independently associated with serious complications. These data help to contextualize outcomes for patients undergoing revisional bariatric procedures and to inform decision making in these patients.
引用
- McLennan S, Verhoeff K, Mocanu V, et al. Characteristics and outcomes for patients undergoing revisional bariatric surgery due to persistent obesity: a retrospective cohort study of 10,589 patients. Surg Endosc. 2023. PMID: 36859722. doi:10.1007/s00464-023-09951-6
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。